Companies: 10,795·Total market cap: $144.5T

NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSNNASDAQHealthcare● Active

$0.75

+$0.00(+0.20%)

Market Cap$18539466

P/E Ratio—

52W High$2.6

52W Low$0.63

Avg Volume152K

Open$0.77

Beta1.54

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

NeuroSense Therapeutics Ltd.（NRSN）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · NRSN · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.38Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding25.5MShares outstanding history

Next EarningsJun 22, 2026Est.Earnings history

探索 NeuroSense Therapeutics Ltd. 数据

分析师预测$— · Buy

股息不分红

盈利EPS $-0.44+20.00%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$11.1M▼ 8.96% YoY

202320242025

FY 2025EPS$-0.44▲ +20.00% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$8.7MEPS: $-0.38View income statement →

分析师评级与目标价

Buy2 位分析师

Strong Buy

0

Buy

1

Hold

1

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$0.75Current

$—Avg Target

$—High

合计: 2 · 买入占比: 50.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

NeuroSense Therapeutics Ltd.

$0.75+0.20%$18.5M #2

CollPlant Biotechnologies Ltd.

$0.37-0.27%$4.5M #3

Cadrenal Therapeutics, Inc. Common Stock

$4.21-5.18%$12.1M #4

Enlivex Therapeutics Ltd.

$0.71+0.59%$17.4M #5

Klotho Neurosciences, Inc.

$0.38-7.10%$20.1M #6

Minerva Neurosciences, Inc.

$4.63-6.65%$32.4M

股票表现

1D+0.20%

1W-6.05%

1M-14.59%

3M-13.21%

YTD-2.26%

1Y-60.44%

5Y-81.40%

关于 NeuroSense Therapeutics Ltd.

CEOAlon Ben-Noon

IPO DateDec 9, 2021

Employees17

CountryIL

Websiteneurosense-tx.com

NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neuro…

Biotechnology HealthcareNASDAQIL

关于股票概览与关键数据

NeuroSense Therapeutics Ltd.（NRSN）是 Biotechnology 行业的 Healthcare 类公司，于 Dec 9, 2021 在 NASDAQ 上市。截至最近交易日，NRSN 股价为 $0.75，市值约为 $18.5M。过去12个月累计回报 -60.44%，年初至今回报 -2.26%。

根据 2 位华尔街分析师，NeuroSense Therapeutics Ltd. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 NeuroSense Therapeutics Ltd. 营收 —，净利润 -$11.1M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，NeuroSense Therapeutics Ltd.（NRSN）股价为 $0.75，在 NASDAQ 上市，52周区间为 $0.63 – $2.60。

NRSN 最新股价NRSN quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议